Description
PIK-293 is an inhibitor of PI3K that is somewhat selective for p110δ PI3K. PIK-293 is the parent compound of PIK-294.
Product Unit Size | Cost | Quantity | Stock |
---|
PIK-293 is an inhibitor of PI3K that is somewhat selective for p110δ PI3K. PIK-293 is the parent compound of PIK-294.
Cas No. | 900185-01-5 |
---|---|
Purity | ≥98% |
Formula | C22H19N7O |
Formula Wt. | 397.43 |
Chemical Name | 2-((4-amino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-5-methyl-3-o-tolylquinazolin-4(3H)-one |
IUPAC Name | 2-[(4-aminopyrazolo[3,4-d]pyrimidin-1-yl)methyl]-5-methyl-3-(2-methylphenyl)quinazolin-4-one |
Synonym | PIK-293, PIK293, PIK 293 |
Solubility | DMSO 80 mg/mL (201.29 mM) Water Insoluble Ethanol Insoluble |
Appearance | Pale Yellow Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Hong J, Dicker B, Jayasinghe S, et al. Strong inhibition of neutrophil-sperm interaction in cattle by selective phosphatidylinositol 3-kinase inhibitors. Biol Reprod. 2017 Nov 1;97(5):671-687. PMID: 29036279.
Setti A, Kumar M, Babu K, et al. Potency and pharmacokinetics of broad spectrum and isoform-specific p110gamma and delta inhibitors in cancers. J Recept Signal Transduct Res. 2016;36(1):26-36. PMID: 26791581.
Martin K, Muessel M, Pullar C, et al. The role of phosphoinositide 3-kinases in neutrophil migration in 3D collagen gels. PLoS One. 2015 Feb 6;10(2):e0116250. PMID: 25659107.
VEGFR, PDGFR, c-Kit inhibitor.
Melanoma-associated antigen.
NSAID; COX-1/2 and PDE inhibitor.
Furanolactone found in Citrus.
BTK inhibitor.
KRAS inhibitor
PKA inhibitor, potential ROCK, S6K1, MSK1, PKB ...
MEK1/2 inhibitor.
BK K+ channel and L-type Ca2+ channel blocker.<...
Sulfonamide; PABA inhibitor.
VEGFR1/2/3, PDGFR, c-Kit, RET inhibitor.
Non-endogenous essential vitamin (B9), found in...
Inhibitor of Akt.
Flavanol originally found in Camilla (green tea...
Coumarin, more potent isomer; VKORC1 inhibitor....
Antioxidant, vitamin E derivative found in vege...
Docetaxel impurity
Third generation macrocyclic ALK inhibitor.
Bumetanide impurity
Read-through agent and nonsense mutation target...